As of 2:30 PM on the 10th, SK Chemicals is trading at 448,000 KRW, down 0.33% from the previous day. The trading volume is 765,222 shares, which is about 65.66% of the previous day's volume. SK Chemicals is known as a manufacturer of eco-friendly materials, energy, and biopharmaceuticals.


On November 10th, Dalmi Lee, a researcher at SK Securities, stated, "Discussions on mass production with AstraZeneca are expected to begin in early 2021, and once production starts, a significant increase in performance is anticipated. Additionally, the company's self-developed COVID-19 vaccine is progressing smoothly. It entered clinical trials at the end of 2020 and aims for a release in the first half of 2022. Inclusion in the MSCI index is also expected to act as a positive momentum for the company's stock price, forecasting a long-term upward trend. There is also potential for additional orders due to factory expansion." The target price for SK Chemicals was set at 540,000 KRW.


Over the past five days, individual investors have net sold 370,386 shares of SK Chemicals, while foreign investors and institutions have net bought 289,453 shares and 69,540 shares, respectively.



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing